drugset / Trial / NCT05119751
Vestibular Versus Sublingual Route of AIT Tablets
Phase 4
Completed
172 enrolled
Clinique Spécialisée en Allergies de la Capitale
ALK-Abelló A/S · collab
RandomizedCrossoverOpen-labelTreatment
Summary
To evaluate the tolerability of the vestibular administration route of birch pollen, grass pollen, ragweed pollen, and house dust mite (HDM) AIT tablets compared with the sublingual route in adult subjects with allergic rhinitis/conjunctivitis (AR/C)
Timeline
- Start
- 2021-10-25
- Primary completion
- 2022-04-05
- Completion
- 2022-04-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | GRASS | Unknown | 2800 unknown | Other |
| Comparator | HDM | Unknown | 12 unknown | Other |
| Comparator | RAGWEED | Unknown | 12 unknown | Other |
| Comparator | tree | Unknown | 12 unknown | Other |